Variants in APOC3 have been implicated in variations of cholesterol and triglyceride levels in SCZ patients treated with clozapine and olanzapine;44 variants in SLC22A23 have been reported to be associated with QT prolongation in a GWAS of subjects with SCZ treated with quetiapine.45 However, comparison of the allele frequency data of the four miR‐708 binding site variants between the 99 WGS subjects with BD and those in reference databases suggested that none of the miR708 3 ′UTR binding site variants were likely to be etiological. The gene discussed is SLC22A23; the disease is Behcet disease.